|Tekla Life Sciences Investors -- USA Fund|| |
USD 20.99 0.01 0.0477%
Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Tekla Life Sciences Investors is 'Buy'
For the selected time horizon Tekla Life Sciences Investors has a risk adjusted performance of 0.1374, jensen alpha of 0.1136, total risk alpha of 0.1229, sortino ratio of 0.1175 and treynor ratio of 0.2797
Macroaxis buy or sell recommendation module can be used to complement current analysts and expert consensus
on Tekla Life Sciences. Our recommendation engine harnesses analyzes the fund potential to grow using all fundamental data market data available at the time. Please be advised to validate Tekla Life Number of Employees
to validate our buy or sell recommendation.
Returns Distribution Density
|Mean Return||0.12||Value At Risk||1.49|
|Potential Upside||1.59||Standard Deviation||0.90|
Tekla Life Greeks
Tekla Life Volatility Alert
Tekla Life Sciences Investors has relatively low volatility with skewness of 0.18 and kurtosis of 1.49. However, we advise all investors to independently investigate Tekla Life Sciences Investors to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.